What is BioPharma Credit PLC (BOPCF)?

BioPharma Credit PLC (BOPCF) is a stock in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of BOPCF?

The current price of BOPCF is $0.93. Prices are updated in real time on Stocks360.

What is BOPCF's price-to-earnings (PE) ratio?

BOPCF's trailing twelve-month PE ratio is 10.24, based on current price and earnings per share data available on Stocks360.

What is BOPCF's market capitalization?

BOPCF's market capitalization is $1,039,374,879.00, placing it in the small-cap tier.

Does BOPCF pay a dividend?

Yes. BOPCF has a trailing twelve-month dividend yield of 0.09%. Dividend data is sourced from financial market providers and displayed on Stocks360.

BioPharma Credit PLC (BOPCF)

Stock analysis · OTC · Financial Services · Asset Management

$0.93

Market Cap

$1.04B

PE (TTM)

10.24

EPS (TTM)

N/A

Dividend Yield

8.65%

Beta

0.10

Day Range

$0.93 – $0.93

52-wk Range

$0.85 – $1.02

Avg Volume

N/A

Volume

99.45K

BioPharma Credit PLC (BOPCF) is a publicly traded company in the Financial Services sector. Latest price: $0.93. Market cap $1.04B. Trailing PE 10.24. Dividend yield 8.65%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-11-04 · $0.89 2026-08-28 · $0.93 (+4.07%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About BioPharma Credit PLC

Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	10.24×
P/S (TTM)	9.09×
P/B	0.97×
P/FCF (TTM)	8.70×
EV / EBITDA	17.98×
EV / Sales	8.52×
Earnings Yield	9.77%
Free Cash Flow Yield	11.50%
Dividend Yield	8.65%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.03B
Revenue (TTM)	$120.51M
Net Income (TTM)	$107.06M
Free Cash Flow (TTM)	$125.94M
Net Debt	-$68.71M
Working Capital	$82.19M
Gross Margin	86.95%
Operating Margin	89.20%
Net Margin	89.20%
Return on Equity	9.39%
Return on Invested Capital	9.44%